Myositis-specific autoantibodies: an important tool to support diagnosis of myositis. - Test2 - elhamkhani - TriplyDB

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

http://www.wikidata.org/entity/Q38646384

about

Selected aspects of the current management of myositis Diagnosis and classification of idiopathic inflammatory myopathies.The EuroMyositis registry: an international collaborative tool to facilitate myositis research.The cutaneous and systemic findings associated with nuclear matrix protein-2 antibodies in adult dermatomyositis patients.Integrated classification of inflammatory myopathies.Pharmacological management of dermatomyositis.Dermatomyositis and Immune-Mediated Necrotizing Myopathies: A Window on Autoimmunity and Cancer.213th ENMC International Workshop: Outcome measures and clinical trial readiness in idiopathic inflammatory myopathies, Heemskerk, The Netherlands, 18-20 September 2015 Recent Approaches To Optimize Laboratory Assessment of Antinuclear Antibodies.Idiopathic inflammatory myopathies overlapping with systemic diseases.2017 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Adult and Juvenile Idiopathic Inflammatory Myopathies and Their Major Subgroups.2017 European League Against Rheumatism/American College of Rheumatology classification criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups.New ways to subclassify patients with myositis.Associations between anti-melanoma differentiation-associated gene 5 antibody and demographics, clinical characteristics and laboratory results of patients with dermatomyositis: A systematic meta-analysis.Anti-melanoma differentiation-associated protein 5 autoantibodies as a marker for dermatomyositis-associated interstitial lung disease.Specific autoantibodies in dermatomyositis: a helpful tool to classify different clinical subsets.[Inflammatory myopathies].Anti-NXP2 antibody-associated extensive subcutaneous calcinosis in adult-onset myositis.Anti-MDA5-positive dermatomyositis: an emerging entity with a variable clinical presentation.Triggers of inflammatory myopathy: insights into pathogenesis.Current Classification and Management of Inflammatory Myopathies.New Myositis Classification Criteria-What We Have Learned Since Bohan and Peter.Seronegative patients form a distinctive subgroup of immune-mediated necrotizing myopathy Investigation of myositis and scleroderma specific autoantibodies in patients with lung cancer

P2860

Q26738952-B9681E1B-C0ED-4D02-9F44-6F13077273CB Q30249522-D81ACF3F-D31D-43A7-9DE2-E282088CD0EF Q38601741-7413AAD2-BFDE-45FB-8C16-23F800ABCD70 Q38995102-64C442B2-31A0-4ACB-8706-0BCDA443F913 Q39027323-6B165C4F-83DC-454A-AF1B-92733E0815E8 Q39425296-76E65086-29CE-49E5-A138-6DE169781D26 Q41485219-3039490A-2B6A-48D7-97F3-044E3B37F22A Q42365042-47983E19-6B71-49DD-BE9F-24E1F50C5A6E Q47103594-2D8E9C8F-5E30-469A-B9D7-0A0684F3FBEE Q47401892-EEF704BA-60A8-4D41-A46B-2988CF97C5CB Q47653276-20EE2475-9730-4CA7-9413-BB6CF2AD1E3C Q47699498-F886877D-968A-426C-B5DE-3450291E3DB7 Q47868107-FCBDF679-A155-4D8B-8570-E74CCD92D911 Q48234140-A14E81E2-F43C-4E63-9BC6-F91F2DA88919 Q51119158-8A9C9F3E-59FD-4DF7-A9F1-8166DFE63E3E Q51280183-04E68D37-1510-473B-9E42-212A5B08B1B7 Q52797027-266EA1F0-36B8-4022-B2B2-9CA506893FD8 Q53786636-7577F5EE-90D7-4F34-9A57-274427C7CB2A Q54151232-1220C71B-CAEE-4F07-B60B-71CB9944CA8C Q54248374-D8633942-FF9E-40E6-8CE7-615428B81CED Q54977148-B4839A34-4104-4F37-84CC-276080181DE9 Q55277507-45BAE9C1-1180-4CE4-B9F3-B27FC6FFB025 Q57814497-D6EC3122-9D9D-4F14-A673-E40745629ECC Q58793465-8A25D58C-0498-49AB-A224-41CEA27DFAC8

P2860

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

http://www.wikidata.org/entity/Q38646384

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh

2015年學術文章

@zh-hant

name

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

@en

type

label

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

@en

prefLabel

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

@en

P1433

Q38646384-55F9A0C7-20CE-4CB5-81EB-41927C43BADD

P1476

Q38646384-7A848B68-60DD-40A5-9BFB-70003A2ED346

P2093

Q38646384-12E292B7-9184-4B4D-A53B-D4119D6BFA78

Q38646384-67CB2078-1337-4934-8EB9-8962DFAA205D

P2860

Q38646384-028C4F61-B03B-4B6A-914E-483C8B10B01D

Q38646384-02A1DD88-AFD9-4802-B2CE-C699F9509C66

Q38646384-12312BCF-4F26-46D1-97D7-05ECCC07BC94

Q38646384-1257C7D8-B441-4BFA-A43C-035E8848A58B

Q38646384-175BB089-FEE4-4E0B-BAA8-3FFEA4307B59

Q38646384-17F6AA2F-AE37-4440-A519-9C137C775C19

Q38646384-19B16896-313D-4777-9753-5A75915BCB3F

Q38646384-1AD3320F-EC64-47C9-81AF-1A462A2D168A

Q38646384-1AE95329-90D8-449B-83D0-CB16549F8B73

Q38646384-1B3CBCEF-0867-4060-8A1F-53A37FBA2C28

P304

Q38646384-F2C185A4-84E2-449C-8025-F35470568DC1

P31

Q38646384-C78C72A8-9443-48C3-99CB-2FB52C661A94

P356

Q38646384-179C95B4-6139-4DAB-8673-F68C49942761

P407

Q38646384-93F35122-5E35-4FCF-A0EC-AC426FAB8CBE

P433

Q38646384-1CB09DEB-57EA-4EB2-97E6-FD999F30AFD5

P478

Q38646384-A0071C77-60F9-4B0F-8542-E5F806DFB8AF

P577

Q38646384-7D835E49-FD37-4924-9772-5BF85451C573

P698

Q38646384-C377F1E4-0EB4-4515-94F8-2A34FC4C7AF8

P921

Q38646384-0BD61F7B-A6A3-474A-B14A-40476CB0C7A6

P356

P1433

Journal of Internal Medicine

P1476

Myositis-specific autoantibodies: an important tool to support diagnosis of myositis.

@en

P2093

N McHugh

http://www.w3.org/2001/XMLSchema#string

Z Betteridge

http://www.w3.org/2001/XMLSchema#string

P2860

Usefulness of anti-p155 autoantibody for diagnosing cancer-associated dermatomyositis: a systematic review and meta-analysis

Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights

Novel conformation of histidyl-transfer RNA synthetase in the lung: the target tissue in Jo-1 autoantibody-associated myositis

RNA helicase encoded by melanoma differentiation-associated gene 5 is a major autoantigen in patients with clinically amyopathic dermatomyositis: Association with rapidly progressive interstitial lung disease.

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients.

Myositis autoantibodies in Korean patients with inflammatory myositis: anti-140-kDa polypeptide antibody is primarily associated with rapidly progressive interstitial lung disease independent of clinically amyopathic dermatomyositis.

Implications in the difference of anti-Mi-2 and -p155/140 autoantibody prevalence in two dermatomyositis cohorts from Mexico City and Guadalajara.

Ultraviolet radiation intensity predicts the relative distribution of dermatomyositis and anti-Mi-2 autoantibodies in women.

Most patients with cancer-associated dermatomyositis have antibodies to nuclear matrix protein NXP-2 or transcription intermediary factor 1γ.

Correlation of anti-signal recognition particle autoantibody levels with creatine kinase activity in patients with necrotizing myopathy.

P304

8-23

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1111/JOIM.12451

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

280

http://www.w3.org/2001/XMLSchema#string

P577

2015-11-25T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26602539

http://www.w3.org/2001/XMLSchema#string

P921